![Howard Levy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Howard Levy
Corporate Officer/Principal bei
Society of Critical Care Medicine
Profil
Howard Levy is a member of the Society of Critical Care Medicine.
He previously worked as a Medical Director-Acute Care at Eli Lilly & Co., Senior Director-Global Medical Program at CSL Behring LLC, Chief Medical Officer at Inspiration Biopharmaceuticals, Inc., Chief Medical Officer at Sangart, Inc., and Associate VP-Clinical Research & Medical at Novo Nordisk, Inc. He also served as the Chief-Critical Care Medicine at The University of New Mexico.
Dr. Levy's education includes a graduate degree from Carnegie Mellon University and a doctorate from the University of the Witwatersrand.
Currently, he is the Chief Medical Officer at Catalyst Biosciences, Inc. and will be the Chief Medical Officer at Ampio Pharmaceuticals, Inc. from 2021 to 2023.
Aktive Positionen von Howard Levy
| Unternehmen | Position | Beginn |
|---|---|---|
Society of Critical Care Medicine
 Society of Critical Care Medicine Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit medical organization that engages in promoting practice of critical care | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Howard Levy
| Unternehmen | Position | Ende |
|---|---|---|
| AMPIO PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2023 |
| CATALYST BIOSCIENCES | Technik-/Wissenschafts-/F&E-Leiter | 15.08.2021 |
Sangart, Inc.
 Sangart, Inc. Pharmaceuticals: MajorHealth Technology Develops blood transfusion solutions | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2011 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Corporate Officer/Principal | 01.01.2008 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Corporate Officer/Principal | - |
Ausbildung von Howard Levy
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
77
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inspiration Biopharmaceuticals, Inc.
 Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Produces intravenous recombinant therapies and develops non-invasive applications | Health Technology |
Sangart, Inc.
Sangart, Inc. Pharmaceuticals: MajorHealth Technology Develops blood transfusion solutions | Health Technology |
The University of New Mexico
 The University of New Mexico Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
University of the Witwatersrand
 University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Society of Critical Care Medicine
Society of Critical Care Medicine Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit medical organization that engages in promoting practice of critical care | Commercial Services |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Ampio Pharmaceuticals, Inc.
 Ampio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immuno modulatory therapies for the treatment of pain from osteoarthritis | Health Technology |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
